Related Experiment Video

Updated: Jul 14, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations

Lianjie Li1, Liang Zhang, Xiaoping Zhang

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, 44 Binney Street, Mayer 457, Boston, MA 02115, USA.

Molecular and Cellular Biology
|May 29, 2007
PubMed

Insights

Von Hippel-Lindau (VHL) disease involves mutations in the VHL tumor suppressor gene. Quantitative differences in hypoxia-inducible factor (HIF) deregulation explain varying kidney cancer risks in VHL disease patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Clear cell kidney carcinoma is a significant cause of mortality in von Hippel-Lindau (VHL) disease, stemming from VHL tumor suppressor gene inactivation.
  • Both familial VHL disease and sporadic clear cell renal carcinomas involve biallelic VHL inactivation.
  • The VHL gene product (pVHL) functions within a ubiquitin ligase complex, degrading hypoxia-inducible factor (HIF) alpha subunits under normoxia.

Purpose of the Study:

  • To investigate the functional differences between VHL mutations associated with varying kidney cancer risks in VHL disease.
  • To elucidate the role of hypoxia-inducible factor (HIF) deregulation in differential kidney cancer risk among VHL disease subtypes.

Main Methods:

  • Reintroduction of type 2A and type 2B VHL mutants into VHL-deficient renal carcinoma cells.
  • Assessment of HIF regulation in cells expressing different VHL mutants.
  • Manipulation of HIF2alpha levels (stabilization or knockdown) to evaluate its impact on tumor cell growth.

Main Results:

  • Type 2A VHL mutants exhibited less severe defects in HIF regulation compared to type 2B mutants.
  • Stabilization of HIF2alpha promoted tumor growth in VHL-/- cells expressing type 2A mutants.
  • HIF2alpha knockdown inhibited tumor growth in cells expressing type 2B mutants.

Conclusions:

  • Quantitative differences in HIF deregulation, rather than qualitative ones, are sufficient to explain the varying kidney cancer risks associated with different VHL mutations.
  • Understanding these quantitative differences in HIF pathway dysregulation is crucial for predicting and potentially managing kidney cancer risk in VHL disease.

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...